News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Aug 1, 2019 Corporate and finance Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019 Download Jul 31, 2019 Partnerships Novavax and Catalent Announce Closing of Strategic Partnership Download Jun 27, 2019 Partnerships Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities Download Jun 27, 2019 Seasonal influenza Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™ Download Jun 10, 2019 RSV Novavax Provides Updates on the Global Pathways to Licensure for ResVax™ Download Jun 4, 2019 Seasonal influenza Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention Download May 10, 2019 Corporate and finance Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023 Download May 8, 2019 Corporate and finance Novavax Announces Reverse Stock Split of Common Stock Download May 2, 2019 Corporate and finance Novavax Reports First Quarter 2019 Financial Results Download May 1, 2019 RSV Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases Download Show 5102550100 per page«1…29303132333435…45»